LBF20207PG54: Difference between revisions
(New page: {{Lipid/Header}} {{Hierarchy|{{PAGENAME}}}} {{Metabolite |LipidBank=XPR1740 |LipidMaps=LMFA03010058 |SysName=9-Methylene- (11alpha,15S) -dihydroxy-prosta- (5-cis,13-trans) -dien-1-oic a...) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Lipid/Header}} | {{Lipid/Header}} | ||
| Line 7: | Line 6: | ||
|LipidBank=XPR1740 | |LipidBank=XPR1740 | ||
|LipidMaps=LMFA03010058 | |LipidMaps=LMFA03010058 | ||
|SysName=9-Methylene- (11alpha,15S) -dihydroxy-prosta- (5- | |SysName=9-Methylene- (11alpha,15S) -dihydroxy-prosta- (cis-5,trans-13) -dien-1-oic acid | ||
|Common Name=&&9-deoxy-9-methylene Prostaglandin E_2&&9-Methylene- (11alpha,15S) -dihydroxy-prosta- (5Z,13E) -dien-1-oic acid&& | |Common Name=&&9-deoxy-9-methylene Prostaglandin E_2&&9-Methylene- (11alpha,15S) -dihydroxy-prosta- (5Z,13E) -dien-1-oic acid&& | ||
|Source= | |Source= | ||
Latest revision as of 08:41, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1740 |
| LipidMaps | LMFA03010058 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG54 |
| 9-deoxy-9-methylene Prostaglandin E2 | |
|---|---|
| |
| Structural Information | |
| 9-Methylene- (11α,15S) -dihydroxy-prosta- (cis-5,trans-13) -dien-1-oic acid | |
| |
| Formula | C21H34O4 |
| Exact Mass | 350.24570957599997 |
| Average Mass | 350.49226 |
| SMILES | C(CC[C@@H](O)C=C[C@@H]([C@@H]1O)[C@H](C(C1)=C)CC=CCCCC(O)=O)CC |
| Physicochemical Information | |
| 9-deoxy-9-methylene Prostaglandin E2 decreases blood pressure in rat and Bundy_GL et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
